Cargando…
Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
OBJECTIVE: The World Health Organization recommends using Xpert MTB/RIF for diagnosis of pulmonary tuberculosis (PTB), but there is little evidence on the optimal placement of Xpert instruments in public health systems. We used recent South African data to compare the cost of placing Xpert at points...
Autores principales: | Schnippel, Kathryn, Meyer-Rath, Gesine, Long, Lawrence, MacLeod, William, Sanne, Ian, Stevens, Wendy S, Rosen, Sydney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506730/ https://www.ncbi.nlm.nih.gov/pubmed/22686606 http://dx.doi.org/10.1111/j.1365-3156.2012.03028.x |
Ejemplares similares
-
The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012) -
Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013) -
The clinical diagnostic value of Xpert MTB/RIF for the detection of Mycobacterium tuberculosis in gastric aspirates
por: Tan, Hong-Kun, et al.
Publicado: (2020) -
Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)